These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7535183)

  • 1. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
    Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K
    Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
    Mo AX; van Lelyveld SF; Craiu A; Rock KL
    J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.
    Niedermann G; Geier E; Lucchiari-Hartz M; Hitziger N; Ramsperger A; Eichmann K
    Immunol Rev; 1999 Dec; 172():29-48. PubMed ID: 10631935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.
    Niedermann G; King G; Butz S; Birsner U; Grimm R; Shabanowitz J; Hunt DF; Eichmann K
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8572-7. PubMed ID: 8710912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
    Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
    J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.
    Shimbara N; Nakajima H; Tanahashi N; Ogawa K; Niwa S; Uenaka A; Nakayama E; Tanaka K
    Genes Cells; 1997 Dec; 2(12):785-800. PubMed ID: 9544705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.
    Khattab B; Eiz-Vesper B; Ganser A; Hertenstein B; Blasczyk R
    Ann Hematol; 2004 Feb; 83(2):107-13. PubMed ID: 14648025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
    Rock KL; York IA; Goldberg AL
    Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses.
    Pamer EG; Sijts AJ; Villanueva MS; Busch DH; Vijh S
    Immunol Rev; 1997 Aug; 158():129-36. PubMed ID: 9314081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
    Gavioli R; Gallerani E; Fortini C; Fabris M; Bottoni A; Canella A; Bonaccorsi A; Marastoni M; Micheletti F; Cafaro A; Rimessi P; Caputo A; Ensoli B
    J Immunol; 2004 Sep; 173(6):3838-43. PubMed ID: 15356131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.
    Gallimore A; Schwarz K; van den Broek M; Hengartner H; Groettrup M
    Mol Immunol; 1998 Jul; 35(10):581-91. PubMed ID: 9823757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
    Serna A; Ramirez MC; Soukhanova A; Sigal LJ
    J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
    Nelson D; Bundell C; Robinson B
    J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm for the prediction of proteasomal cleavages.
    Kuttler C; Nussbaum AK; Dick TP; Rammensee HG; Schild H; Hadeler KP
    J Mol Biol; 2000 May; 298(3):417-29. PubMed ID: 10772860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
    Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
    J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.